Global Aurora Kinase B market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get Access Now!

Global Aurora Kinase B Market Size and Outlook 2025-31

The global Aurora Kinase B market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. United States market for Aurora Kinase B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Aurora Kinase B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Aurora Kinase B is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Aurora Kinase B players cover AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, Amgen Inc, AstraZeneca Plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Aurora Kinase B Industry Forecast looks at past sales and reviews total world Aurora Kinase B sales in 2024, providing a comprehensive analysis by region and market sector of projected Aurora Kinase B sales for 2025 through 2031. With Aurora Kinase B sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aurora Kinase B industry. This Insight Report provides a comprehensive analysis of the global Aurora Kinase B landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aurora Kinase B portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Aurora Kinase B market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aurora Kinase B and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aurora Kinase B. This report presents a comprehensive overview, market shares, and growth opportunities of Aurora Kinase B market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; AZD-2811 &nbsp;&nbsp;&nbsp; CS-2164 &nbsp;&nbsp;&nbsp; Danusertib &nbsp;&nbsp;&nbsp; Ilorasertib &nbsp;&nbsp;&nbsp; NMI-900 &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Anaplastic Large Cell Lymphoma &nbsp;&nbsp;&nbsp; Kidney Cancer &nbsp;&nbsp;&nbsp; Lung Cancer &nbsp;&nbsp;&nbsp; Prostate Cancer &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; AbbVie Inc &nbsp;&nbsp;&nbsp; Advenchen Laboratories LLC &nbsp;&nbsp;&nbsp; Aeterna Zentaris Inc &nbsp;&nbsp;&nbsp; Amgen Inc &nbsp;&nbsp;&nbsp; AstraZeneca Plc &nbsp;&nbsp;&nbsp; Chipscreen Biosciences Ltd &nbsp;&nbsp;&nbsp; Cielo Therapeutics Inc &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Sareum Holdings Plc Key Questions Addressed in this Report What is the 10-year outlook for the global Aurora Kinase B market? What factors are driving Aurora Kinase B market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Aurora Kinase B market opportunities vary by end market size? How does Aurora Kinase B break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Aurora Kinase B Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Aurora Kinase B by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Aurora Kinase B by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Aurora Kinase B Segment by Type &nbsp;2.2.1 AZD-2811 &nbsp;2.2.2 CS-2164 &nbsp;2.2.3 Danusertib &nbsp;2.2.4 Ilorasertib &nbsp;2.2.5 NMI-900 &nbsp;2.2.6 Others &nbsp;2.3 Aurora Kinase B Sales by Type &nbsp;2.3.1 Global Aurora Kinase B Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Aurora Kinase B Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Aurora Kinase B Sale Price by Type (2020-2025) &nbsp;2.4 Aurora Kinase B Segment by Application &nbsp;2.4.1 Anaplastic Large Cell Lymphoma &nbsp;2.4.2 Kidney Cancer &nbsp;2.4.3 Lung Cancer &nbsp;2.4.4 Prostate Cancer &nbsp;2.4.5 Others &nbsp;2.5 Aurora Kinase B Sales by Application &nbsp;2.5.1 Global Aurora Kinase B Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Aurora Kinase B Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Aurora Kinase B Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Aurora Kinase B Breakdown Data by Company &nbsp;3.1.1 Global Aurora Kinase B Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Aurora Kinase B Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Aurora Kinase B Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Aurora Kinase B Revenue by Company (2020-2025) &nbsp;3.2.2 Global Aurora Kinase B Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Aurora Kinase B Sale Price by Company &nbsp;3.4 Key Manufacturers Aurora Kinase B Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Aurora Kinase B Product Location Distribution &nbsp;3.4.2 Players Aurora Kinase B Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Aurora Kinase B by Geographic Region &nbsp;4.1 World Historic Aurora Kinase B Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Aurora Kinase B Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Aurora Kinase B Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Aurora Kinase B Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Aurora Kinase B Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Aurora Kinase B Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Aurora Kinase B Sales Growth &nbsp;4.4 APAC Aurora Kinase B Sales Growth &nbsp;4.5 Europe Aurora Kinase B Sales Growth &nbsp;4.6 Middle East & Africa Aurora Kinase B Sales Growth 5 Americas &nbsp;5.1 Americas Aurora Kinase B Sales by Country &nbsp;5.1.1 Americas Aurora Kinase B Sales by Country (2020-2025) &nbsp;5.1.2 Americas Aurora Kinase B Revenue by Country (2020-2025) &nbsp;5.2 Americas Aurora Kinase B Sales by Type (2020-2025) &nbsp;5.3 Americas Aurora Kinase B Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Aurora Kinase B Sales by Region &nbsp;6.1.1 APAC Aurora Kinase B Sales by Region (2020-2025) &nbsp;6.1.2 APAC Aurora Kinase B Revenue by Region (2020-2025) &nbsp;6.2 APAC Aurora Kinase B Sales by Type (2020-2025) &nbsp;6.3 APAC Aurora Kinase B Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Aurora Kinase B by Country &nbsp;7.1.1 Europe Aurora Kinase B Sales by Country (2020-2025) &nbsp;7.1.2 Europe Aurora Kinase B Revenue by Country (2020-2025) &nbsp;7.2 Europe Aurora Kinase B Sales by Type (2020-2025) &nbsp;7.3 Europe Aurora Kinase B Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Aurora Kinase B by Country &nbsp;8.1.1 Middle East & Africa Aurora Kinase B Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Aurora Kinase B Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Aurora Kinase B Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Aurora Kinase B Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Aurora Kinase B &nbsp;10.3 Manufacturing Process Analysis of Aurora Kinase B &nbsp;10.4 Industry Chain Structure of Aurora Kinase B 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Aurora Kinase B Distributors &nbsp;11.3 Aurora Kinase B Customer 12 World Forecast Review for Aurora Kinase B by Geographic Region &nbsp;12.1 Global Aurora Kinase B Market Size Forecast by Region &nbsp;12.1.1 Global Aurora Kinase B Forecast by Region (2026-2031) &nbsp;12.1.2 Global Aurora Kinase B Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Aurora Kinase B Forecast by Type (2026-2031) &nbsp;12.7 Global Aurora Kinase B Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 AbbVie Inc &nbsp;13.1.1 AbbVie Inc Company Information &nbsp;13.1.2 AbbVie Inc Aurora Kinase B Product Portfolios and Specifications &nbsp;13.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 AbbVie Inc Main Business Overview &nbsp;13.1.5 AbbVie Inc Latest Developments &nbsp;13.2 Advenchen Laboratories LLC &nbsp;13.2.1 Advenchen Laboratories LLC Company Information &nbsp;13.2.2 Advenchen Laboratories LLC Aurora Kinase B Product Portfolios and Specifications &nbsp;13.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Advenchen Laboratories LLC Main Business Overview &nbsp;13.2.5 Advenchen Laboratories LLC Latest Developments &nbsp;13.3 Aeterna Zentaris Inc &nbsp;13.3.1 Aeterna Zentaris Inc Company Information &nbsp;13.3.2 Aeterna Zentaris Inc Aurora Kinase B Product Portfolios and Specifications &nbsp;13.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Aeterna Zentaris Inc Main Business Overview &nbsp;13.3.5 Aeterna Zentaris Inc Latest Developments &nbsp;13.4 Amgen Inc &nbsp;13.4.1 Amgen Inc Company Information &nbsp;13.4.2 Amgen Inc Aurora Kinase B Product Portfolios and Specifications &nbsp;13.4.3 Amgen Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Amgen Inc Main Business Overview &nbsp;13.4.5 Amgen Inc Latest Developments &nbsp;13.5 AstraZeneca Plc &nbsp;13.5.1 AstraZeneca Plc Company Information &nbsp;13.5.2 AstraZeneca Plc Aurora Kinase B Product Portfolios and Specifications &nbsp;13.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 AstraZeneca Plc Main Business Overview &nbsp;13.5.5 AstraZeneca Plc Latest Developments &nbsp;13.6 Chipscreen Biosciences Ltd &nbsp;13.6.1 Chipscreen Biosciences Ltd Company Information &nbsp;13.6.2 Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolios and Specifications &nbsp;13.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Chipscreen Biosciences Ltd Main Business Overview &nbsp;13.6.5 Chipscreen Biosciences Ltd Latest Developments &nbsp;13.7 Cielo Therapeutics Inc &nbsp;13.7.1 Cielo Therapeutics Inc Company Information &nbsp;13.7.2 Cielo Therapeutics Inc Aurora Kinase B Product Portfolios and Specifications &nbsp;13.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Cielo Therapeutics Inc Main Business Overview &nbsp;13.7.5 Cielo Therapeutics Inc Latest Developments &nbsp;13.8 Sanofi &nbsp;13.8.1 Sanofi Company Information &nbsp;13.8.2 Sanofi Aurora Kinase B Product Portfolios and Specifications &nbsp;13.8.3 Sanofi Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Sanofi Main Business Overview &nbsp;13.8.5 Sanofi Latest Developments &nbsp;13.9 Sareum Holdings Plc &nbsp;13.9.1 Sareum Holdings Plc Company Information &nbsp;13.9.2 Sareum Holdings Plc Aurora Kinase B Product Portfolios and Specifications &nbsp;13.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Sareum Holdings Plc Main Business Overview &nbsp;13.9.5 Sareum Holdings Plc Latest Developments 14 Research Findings and Conclusion

Report	Global Aurora Kinase B Market Growth 2025-2031
Selected License	Single ID:LPI23633

Buyer Information

Order Summary